{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:42:26Z","timestamp":1782690146970,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.tripleo.2009.06.021","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T14:57:43Z","timestamp":1253717863000},"page":"e13-e19","source":"Crossref","is-referenced-by-count":13,"title":["Necrotizing stomatitis: a possible periodontal manifestation of deferiprone-induced agranulocytosis"],"prefix":"10.1016","volume":"108","author":[{"given":"Shikha","family":"Tewari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajinder K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Abrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2009.06.021_bib1","first-page":"704","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"1 Weatherall","year":"2001","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.tripleo.2009.06.021_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1749-6632.1998.tb10482.x","article-title":"Global epidemiology of hemoglobin disorders","volume":"850","author":"Angastiniotis","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tripleo.2009.06.021_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02982791","article-title":"Iron toxicity and chelation therapy","volume":"76","author":"Britton","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib4","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis","volume":"88","author":"Piga","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.tripleo.2009.06.021_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2009.06.021_bib6","first-page":"299","article-title":"Deferiprone therapy for transfusional iron overloads","volume":"18","author":"Hoffbrand","year":"2005","journal-title":"Clin Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1749-6632.1998.tb10478.x","article-title":"A multi-center safety trial of the oral iron chelator deferiprone","volume":"850","author":"Cohen","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tripleo.2009.06.021_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2141.2000.01866.x","article-title":"Safety profile of the oral iron chelator deferiprone: a multicenter study","volume":"108","author":"Cohen","year":"2000","journal-title":"Br. J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2002-10-3280","article-title":"Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone","volume":"102","author":"Cohen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2009.06.021_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2141.2002.03554.x","article-title":"The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients","volume":"118","author":"Ceci","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0609.1994.tb01323.x","article-title":"Deferiprone-associated myelotoxicity","volume":"53","author":"Al-Refaie","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2141.1995.tb05274.x","article-title":"Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators","volume":"91","author":"Al-Refaie","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib13","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/blood-2007-02-065805","article-title":"Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia","volume":"109","author":"Henter","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2009.06.021_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1079-2104(96)80148-X","article-title":"Treatment of neutropenic oral ulceration in human immunodeficiency virus infection with G-CSF","volume":"8","author":"Luzzi","year":"1996","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2009.06.021_bib15","series-title":"Harrison's principles of internal medicine","first-page":"617","article-title":"Aplastic anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes","author":"Young","year":"2005"},{"key":"10.1016\/j.tripleo.2009.06.021_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0973-029X.37740","article-title":"Neutrophils in health and disease: An overview","volume":"10","author":"Rashmi","year":"2006","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0268-960X(88)90023-9","article-title":"Cycic neutropenia: a clinical review","volume":"2","author":"Dale","year":"1988","journal-title":"Blood Rev"},{"key":"10.1016\/j.tripleo.2009.06.021_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andr\u00e8s","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00002018-199411060-00006","article-title":"Idiosyncratic drug-induced haematological abnormalities: incidence, pathogenesis, management and avoidance","volume":"11","author":"Patton","year":"1994","journal-title":"Drug Safety"},{"key":"10.1016\/j.tripleo.2009.06.021_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-051X.1998.tb02437.x","article-title":"Gingival ulceration in HIV infection: a case series and case control","volume":"25","author":"Robinson","year":"1998","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1834-7819.1998.tb00144.x","article-title":"A case of chronic severe neutropenia: oral findings and consequences of short-term granulocyte colony-stimulating factor treatment","volume":"43","author":"Hasturk","year":"1998","journal-title":"Aust Dent J"},{"key":"10.1016\/j.tripleo.2009.06.021_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.bdj.4805758","article-title":"Neutropenia and dental patients","volume":"160","author":"Scully","year":"1986","journal-title":"Br Dent J"},{"key":"10.1016\/j.tripleo.2009.06.021_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1902\/jop.1987.58.1.51","article-title":"Neutropenic ulceration","volume":"58","author":"Barrett","year":"1987","journal-title":"J Periodontol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0891-5520(05)70115-X","article-title":"Oral complications associated with immunosuppression and cancer therapies","volume":"13","author":"Epstein","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.tripleo.2009.06.021_bib25","first-page":"108","article-title":"Necrotising periodontal diseases","volume":"9","author":"Bermejo-Fenoll","year":"2004","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.tripleo.2009.06.021_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1902\/annals.1999.4.1.74","article-title":"Necrotizing ulcerative periodontitis","volume":"4","author":"Novak","year":"1999","journal-title":"Ann Periodontol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","article-title":"Iron-chelating therapy and the treatment of thalassemia","volume":"89","author":"Olivieri","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2009.06.021_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0609.2006.00773.x","article-title":"Peripheral blood haematopoietic progenitor cells in patients with beta thalassaemia major receiving desferrioxamine or deferiprone as chelation therapy","volume":"78","author":"Vlachaki","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199504063321404","article-title":"Iron-chelation therapy with oral deferiprone in patients with thalassemia major","volume":"332","author":"Olivieri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.06.021_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199808133390701","article-title":"Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major","volume":"339","author":"Olivieri","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.06.021_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/bcmd.2002.0510","article-title":"Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial","volume":"28","author":"Maggio","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tripleo.2009.06.021_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2009.06.021_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","article-title":"Combined therapy with deferiprone and desferrioxamine","volume":"103","author":"Wonke","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcmd.2005.11.002","article-title":"Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial","volume":"36","author":"Kattamis","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tripleo.2009.06.021_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.04240.x","article-title":"Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients","volume":"121","author":"Mourad","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2009.06.021_bib36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/156652408786241438","article-title":"Current status in iron chelation in hemoglobinopathies","volume":"8","author":"Cappellini","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.tripleo.2009.06.021_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1079-2104(99)70086-7","article-title":"Hematologic abnormalities among HIV-infected patient: Associations of significance for dentistry","volume":"88","author":"Patton","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2009.06.021_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bdj.4810660","article-title":"Dental management considerations for the patient with an acquired coagulopathy","volume":"195","author":"Lockhart","year":"2003","journal-title":"Br Dent J"},{"key":"10.1016\/j.tripleo.2009.06.021_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0011-8532(22)00213-0","article-title":"Treatment of patients with bleeding disorders","volume":"38","author":"Patton","year":"1994","journal-title":"Dent Clin North Am"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107921040900420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107921040900420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T21:43:14Z","timestamp":1685137394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107921040900420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S107921040900420X"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2009.06.021","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}